ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 358

Parity and Severity of ACPA-Positive/Negative Rheumatoid Arthritis. Results from the Swedish EIRA Study

Mitra Pikwer1, Cecilia Orellana2, Henrik Källberg2, Andreas Pikwer3, Carl Turesson4, Lars Klareskog5, Lars Alfredsson6,7, Saedis Saevarsdottir8 and Camilla Bengtsson9, 1Rheumatology Unit, Mälarhospital, Institute of Environmental Medicine, Eskilstuna, Sweden, 2Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden, 3Centre of Clinical Research Sörmland, Eskilstuna, Sweden, 4Rheumatology, Department of Clinical Sciences, Malmö, Sweden, 5Medicine, Rheumatology Unit, Karolinska University Hospital, Karolinska institutet, Stockholm, Sweden, 6Institute of Environmental Medicine, Stockholm, Sweden, 7Centre of Occupational and Environmental Medicine, Stockholm, Sweden, 8Institute of Environmental Medicine, Karolinska Institutet,, Stockholm, Sweden, 9The Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Epidemiologic methods, hormones and rheumatoid arthritis (RA)

  • Tweet
  • Email
  • Print
Session Information

Title: Rheumatoid Arthritis - Clinical Aspects: Novel Biomarkers and Other Measurements of Disease Activity

Session Type: Abstract Submissions (ACR)

Background/Purpose

Female sex and older age are known risk factors for rheumatoid arthritis (RA). The disease is however heterogeneous, and a common division occurs between the presence/absence of autoantibodies to citrullinated peptide antigens (ACPA) where ACPA-positive disease generally has a worse outcome. In a recent study we reported that parous women of reproductive age (18 to 44 years at diagnosis) had an increased risk of ACPA-negative, but not of ACPA-positive RA, and that this association was stronger closer to partum[1]. There are diverging results regarding the effect of parity on the severity of RA.

Our purpose was to explore if parity has impact on disease severity of RA, stratified into different phenotypes.

Methods

We studied female RA cases aged 18-70, who participated in the Epidemiological Investigation of Rheumatoid arthritis, EIRA, a population-based case-control study from the middle and southern parts of Sweden. All patients included fulfilled the American Collage of Rheumatology (ACR) 1987 criteria for RA and were diagnosed by a rheumatologist, and included within 1 year of diagnosis. Information on disease severity (Health Assessment Questionnaire, HAQ and disease activity score 28, DAS28) was gathered from the Swedish Rheumatology Register, SRQ at inclusion, 3, 6, 12 and 24 months after diagnosis. Mixed models for repeated measurements over time were used to take account of the variation at different time point at individual level and to compare mean DAS28 and HAQ-scores over time. ANCOVA analysis was used to compare mean differences of clinical outcome measures at all time points

Results

A total of 1237 female cases, with complete information, were included in the study with a mean age of 51 at inclusion.  In all, 82% had ever given birth to a child before diagnosis and 65 % were ACPA-positive. Mixed models analysis showed associations between parity and ACPA negative but not ACPA positive disease. Parous women, aged 18-44, who would develop ACPA negative disease, had on average 1.17 higher DAS 28 (p< 0.001) and 0.43 higher HAQ  (p< 0.001) compared to nulliparous women during the follow up time, adjusted for age. These findings remained after individually adjustment for smoking, living area and level of education. There was an opposite trend among parous ACPA negative women (aged 45 to 70), were parous women had 0.26 lower DAS 28 (p=0.14) and 0.06 lower HAQ (p=0.46). ANCOVA analysis for different time points noted an association between higher DAS 28 and HAQ levels and parity in the ACPA negative reproductive age group at all time points, except at baseline. In ACPA negative older age group we observed a milder disease in parous women, although only significant at baseline.

Conclusion

Parity influenced ACPA negative disease, where parous women who developed RA during their fertile years had on average higher DAS 28 and HAQ compared to nulliparous women. Parity was not a predictor of severity in ACPA positive disease.

References

1. Orellana C, Wedren S, Kallberg H, et al. Parity and the risk of developing rheumatoid arthritis: results from the Swedish Epidemiological Investigation of Rheumatoid Arthritis study. Annals of the Rheumatic Diseases2013.

 


Disclosure:

M. Pikwer,
None;

C. Orellana,
None;

H. Källberg,
None;

A. Pikwer,
None;

C. Turesson,
None;

L. Klareskog,
None;

L. Alfredsson,
None;

S. Saevarsdottir,
None;

C. Bengtsson,
None.

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/parity-and-severity-of-acpa-positivenegative-rheumatoid-arthritis-results-from-the-swedish-eira-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology